制造莫达菲尼尔:药物开发中的分类和偶然性
Stephen J Scholte1, Ohid Yaqub1
1Science Policy Research Unit (SPRU), University of Sussex, Brighton, East Sussex, UK.
Social studies of science
|March 18, 2025
概括
药物开发涉及分类和偶然性,正如我们在modafinil中看到的那样. 这一过程,特别是对于心理健康化合物,需要大量的机构努力来建立市场和导航监管途径.
科学领域:
- 药理学和药物开发领域
- 医学史和社会学医学史和社会学
- 心理健康政策 心理健康政策
背景情况:
- 了解一种化合物的旅程,从发现到上市药物是复杂的.
- 偶然性和分类在塑造药物开发途径中的作用往往被低估.
- 心理健康药物开发在市场创建和监管导航方面面临着独特的挑战.
研究的目的:
- 用modafinil作为案例研究来研究分类和偶然性如何影响药物开发.
- 探索心理健康类别与药物开发过程之间的相互作用.
- 突出药品商业化所需的机构努力和市场建设.
主要方法:
- 莫达菲尼尔发展轨迹的历史分析.
- 追溯该化合物的偶然发现 (CRL40,476) 和随后的开发重点.
- 检查摩达菲尼尔的监管分类 (第四名单,孤儿药物) 和市场地位的谈判.
主要成果:
- 莫达菲尼尔的发展是由无意中创造和随后的战略分类努力所塑造的.
- 该化合物通过谈判过程获得了第四计划,孤儿药物,并最终获得了大片药物地位.
- 为了建立市场和获得监管部门的批准,需要进行重大制度调整.
结论:
- 药物开发,特别是在心理健康领域,涉及到大量的,往往被低估的,在市场创造和分类方面的努力.
- 认识到这些意外情况至关重要,以避免将发明与创新混为一谈,并准确评估开发成本.
- 莫达菲尼尔案例说明了科学发现,监管框架和市场力量的复杂相互作用.
相关概念视频
Pharmacovigilance
762
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
762
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Structure-Activity Relationships and Drug Design
471
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
471
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Classes and Categories
1.9K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.9K
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K


